Drugs that contain Doxepin Hydrochloride
1. Drug name - SILENOR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10653662 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
May, 2027
(4 years from now) | |
| US9486437 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
May, 2027
(4 years from now) | |
| US9861607 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
May, 2027
(4 years from now) | |
| US10238620 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
May, 2027
(4 years from now) | |
| US10653660 | CURRAX | Methods of improving the pharmacokinetics of doxepin |
Jul, 2027
(4 years from now) | |
| US11110074 | CURRAX | Methods of improving the pharmacokinetics of doxepin |
Jul, 2027
(4 years from now) | |
| US9572814 | CURRAX | Methods of improving the pharmacokinetics of doxepin |
Jul, 2027
(4 years from now) | |
| US7915307 | CURRAX | Methods of improving the pharmacokinetics of doxepin |
Aug, 2027
(4 years from now) | |
| US11234954 | CURRAX | Low-dose doxepin for treatment of sleep disorders in elderly patients |
Jan, 2028
(5 years from now) | |
| US9907780 | CURRAX | Low-dose doxepin formulations and methods of making and using the same |
Apr, 2028
(5 years from now) | |
| US10548871 | CURRAX | Low-dose doxepin formulations and methods of making and using the same |
Apr, 2028
(5 years from now) | |
| US11096920 | CURRAX | Low-dose doxepin formulations and methods of making and using the same |
Apr, 2028
(5 years from now) | |
| US9107898 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
May, 2028
(5 years from now) | |
| US9532971 | CURRAX | Low-dose doxepin formulations and methods of making and using the same |
Jun, 2029
(6 years from now) | |
| US8513299 | CURRAX | Methods of using low-dose doxepin for the improvement of sleep |
Sep, 2030
(7 years from now) | |
Treatment: Treatment of insomnia
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 3MG BASE | TABLET;ORAL | Prescription |
| EQ 6MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.